Alex Aronov

This inventor holds 26 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in Protein Kinase Inhibitors. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2004-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alex Aronov. Retrieved from https://idiyas.com/inventor/alex-aronov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 26 (Patent Applications = 5)

% Patents Active = 30.8

CIPO Patents = 4

EPO Patents = 10 (Patent Applications = 12)

Average Co-Inventor Count = 7.0

ph-index = 15

Forward Citations = 527(Granted Patents)

Location History:

Watertown, MA (US) (2004 - 2012)
Newton, MA (US) (2011 - 2019)

Company Filing History:

26 out of 1,168

Vertex Pharmaceuticals, Inc.

patents

Years Active: 2004-2019

Loading Chart...

Areas of Expertise:

Phosphatidylinositol 3-Kinase

JAK Inhibitors

Protein Kinases

Isoindolinone

Azaindoles

Pyrazolo[1,5-a]Pyrimidines

Heterocyclic Compounds

Tri-Cyclic Pyrazolopyridine

Indazolinone

Heteroaryl Compounds

Imidazole

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10301304 - Selective inhibitor of phosphatidylinositol 3-kinase-gamma (2019-05-28),

2. 10183933 - Isoindolinone inhibitors of phosphatidylinositol 3-kinase (2019-01-22),

3. 9676759 - Isoindolinone inhibitors of phosphatidylinositol 3-kinase (2017-06-13),

4. 8987454 - Azaindoles useful as inhibitors of JAK and other protein kinases (2015-03-24),

5. 8722889 - Azaindoles useful as inhibitors of JAK and other protein kinases (2014-05-13),

6. 8686143 - Compounds useful as inhibitors of Janus kinases (2014-04-01),

7. 8524906 - Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase (2013-09-03),

8. 8501446 - Azaindoles useful as inhibitors of JAK and other protein kinases (2013-08-06),

9. 8466288 - Isoindolinone inhibitors of phosphatidylinositol 3-kinase (2013-06-18),

10. 8344153 - Inhibitors of phosphatidylinositol 3-kinase (2013-01-01),

11. 8268999 - Tri-cyclic pyrazolopyridine kinase inhibitors (2012-09-18),

12. 8188281 - Azaindoles useful as inhibitors of JAK and other protein kinases (2012-05-29),

13. 7998987 - Inhibitors of c-Met and uses thereof (2011-08-16),

14. 7842712 - Indazolinone compositions useful as kinase inhibitors (2010-11-30),

15. 7547794 - Compositions useful as inhibitors of protein kinases (2009-06-16),

Title: Alex Aronov: Innovator in Pharmaceutical Development

Introduction

Alex Aronov is a highly accomplished inventor based in Watertown, MA, with an impressive portfolio of 26 patents to his name. His contributions to the field of pharmaceuticals have made significant impacts in the development of innovative treatments for various diseases.

Latest Patents

Among his latest inventions are several cutting-edge patents that focus on inhibitors of phosphatidylinositol 3-kinase (PI3K). One notable patent is for a selective inhibitor of phosphatidylinositol 3-kinase-gamma, emphasizing compounds that can be useful in treating a range of diseases, conditions, or disorders. Another recent patent involves isoindolinone inhibitors of phosphatidylinositol 3-kinase, aimed at providing pharmaceutically acceptable compositions that can further advance therapeutic applications in the medical field.

Career Highlights

Alex Aronov currently works at Vertex Pharmaceuticals, Inc., a leading company in the pharmaceutical industry known for its commitment to innovative therapies. His research and development efforts have played a crucial role in the company’s mission to transform the lives of people with serious diseases.

Collaborations

Alex collaborates with esteemed colleagues, including Jon H. Come and David J. Lauffer. Together, they drive innovations that push the boundaries of pharmaceutical advancements and enhance treatment options for patients.

Conclusion

Alex Aronov stands out as a prominent inventor whose work in pharmaceutical sciences is making a tangible difference in patient care. His dedication to research and innovative solutions continues to inspire advancements in medical therapies, proving the vital role of inventors in shaping the future of healthcare.

Profile summary based on public USPTO records.